Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations
- Western blot [3]
Submit
Validation data
Reference
Comment
Report error
- Product number
- H00010694-B02P - Provider product page
- Provider
- Novus Biologicals
- Proper citation
- Novus Cat#H00010694-B02P, RRID:AB_2073920
- Product name
- Mouse Polyclonal CCT8 Antibody
- Antibody type
- Polyclonal
- Description
- Protein A purified. Reacts with chaperonin containing TCP1, subunit 8 (theta).
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Vial size
- 0.05 mg
- Storage
- Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
Submitted references The TRiC chaperonin controls reovirus replication through outer-capsid folding.
Modulation of heat shock transcription factor 1 as a therapeutic target for small molecule intervention in neurodegenerative disease.
Knowlton JJ, Fernández de Castro I, Ashbrook AW, Gestaut DR, Zamora PF, Bauer JA, Forrest JC, Frydman J, Risco C, Dermody TS
Nature microbiology 2018 Apr;3(4):481-493
Nature microbiology 2018 Apr;3(4):481-493
Modulation of heat shock transcription factor 1 as a therapeutic target for small molecule intervention in neurodegenerative disease.
Neef DW, Turski ML, Thiele DJ
PLoS biology 2010 Jan 19;8(1):e1000291
PLoS biology 2010 Jan 19;8(1):e1000291
No comments: Submit comment
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Western Blot: CCT8 Antibody [H00010694-B02P] - Analysis of CCT8 expression in transfected 293T cell line by CCT8 polyclonal antibody. Lane 1: CCT8 transfected lysate(60.28 KDa). Lane 2: Non-transfected lysate.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Western Blot: CCT8 Antibody [H00010694-B02P] - Analysis of CCT8 expression in human spleen.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Western Blot: CCT8 Antibody [H00010694-B02P] - Analysis of CCT8 expression in Jurkat.
